AbbVie news：AbbVie News Center
AbbVie News Center
2023年8月28日—AbbVieInc.Newsroom-theofficialsiteforpressreleases,photos,video,audio,prcontactinformation,presskitsandmore.。其他文章還包含有：「AbbVie」、「AbbVieAppearstoWinMostof$480MillionItSoughtFrom...」、「AbbVieInc.(ABBV)LatestPressReleases&CorporateNews」、「AbbVieInc.(ABBV)StockPrice」、「AbbVieNews」、「AbbVie」、「CorporateNews」、「Pressreleases」
查看更多 離開網站
AbbVie
https://www.fiercepharma.com
AbbVie is crying foul against Mark Cuban's drug company and Coherus' attempt to sell a Humira biosimilar at an 85% discount. Kevin Dunleavy Jun 15, 2023 11:10am.
AbbVie Appears to Win Most of $480 Million It Sought From ...
https://news.bloomberglaw.com
AbbVie Endocrine Inc. won a court ruling in Delaware on Tuesday that appeared to award the drug giant most of the $480.6 million it sought ...
AbbVie Inc. (ABBV) Latest Press Releases & Corporate News
https://finance.yahoo.com
AbbVie (NYSE: ABBV) today announced that the European Commission has approved AQUIPTA® (atogepant) for the prophylaxis of migraine in adults who have four or ...
AbbVie Inc. (ABBV) Stock Price
https://finance.yahoo.com
AbbVie (ABBV) closed at $146.10 in the latest trading session, marking a -1.42% move from the prior day.
AbbVie News
https://news.abbvie.com
Latest press releases, new stories, and other breaking company news. ... AbbVie combines advanced science, expertise and passion to solve serious health ...
AbbVie
https://www.abbvie.com
AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's ...
Corporate News
https://news.abbvie.com
NORTH CHICAGO, Ill., July 6, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its second-quarter 2023 financial results on Thursday, July 27, 2023, before ...
Press releases
https://news.abbvie.com
6, 2023 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV) today announced the next chapter of the BOTOX® Cosmetic and IFundWomen grant program ...